Media Contacts

For more information contact our media team:

Stacy Sevcik
+1 314 529 3062
Send Email >

Next Event

  • ISPOR 19th Annual European Congress

    Vienna, Austria
    Nov29 – 2, 2016

    Learn More

Kantar Health thought leaders are available to comment on a variety of healthcare- and pharma-industry-related topics. In addition, our proprietary data is available for media use, including patient population sizes, treatment rates and patient-reported behaviors and attitudes.

Welcome to the Kantar Health News Room RSS Feed News

Delivering the most current and unique insights on healthcare trends and news about Kantar Health.

Evidências-Kantar Health Wins Clinical Research Award in Brazil

Apr 17, 2015

SÃO PAULO, April 17, 2015—Evidências, a Kantar Health company, was awarded the 2014 Excellent Clinical Research Professional by the Brazilian Association of Clinical Research Organizations (ABRACRO). The team received the award for “Observational Studies in Public Health: Ethical Brazilian System Critical Assessment” on April 8.

Authored by Eimy Minowa, Guilherme Julian, Alexandra Piedade, Christiane Bueno and Luciana Clark, the paper analyzes the panorama of the ethical system in Brazil, assessing problems and offering possible solutions to make the process more agile and effective.

The award is an initiative from ABRACRO with the goal to stimulate clinical research, develop new methods and promote clinical research professionals while rewarding innovative studies in this area. ABRACRO represents clinical research organizations established in Brazil with the objective to contribute to and improve the regulatory clinical research processes in the country, thus encouraging and developing scientific activities in this area.

“Real-world studies are important to build evidence-based public health policies and support decision making on healthcare. However, bureaucracy and unclear pathways for ethics requirements for observational studies are great challenges in the development of these studies in Brazil,” Evidências President Otavio Clark said. “Evidências’ studies address the importance of observational studies, the difficulties concerning their ethical regulation and the need of specific recommendations to improve Brazilian ethics system in order to develop public health policies in Brazil.”

The studies will be presented at the upcoming meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) May 16-20 in Philadelphia.

About Evidências

Founded in 1998, Evidências aims to solve healthcare questions through evidence-based medicine techniques and assist in the decision-making process for market access of new technologies. Evidências has established itself as a leading company in healthcare solutions, assisting clients across Brazil in all segments. As we provide services to healthcare providers, hospitals, pharmaceutical and medical devices industries and the public sector we truly understand the intrinsic needs of each segment and obtain a global view of the market.

About Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 600+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. Kantar Health is part of Kantar, the data investment management division of WPP. For more information, please visit